High dose methylphenidate in the treatment of freezing of gait in advanced Parkinson's disease
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Basal Ganglia
- Vol. 11, 8-13
Abstract
No abstract availableKeywords
Funding Information
- David Devos
This publication has 27 references indexed in Scilit:
- Freezing of gait: moving forward on a mysterious clinical phenomenonThe Lancet Neurology, 2011
- Methylphenidate for gait impairment in Parkinson diseaseNeurology, 2011
- Methylphenidate for the Treatment of Parkinson Disease and Other Neurological DisordersClinical Neuropharmacology, 2009
- Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Medical treatment of freezing of gaitMovement Disorders, 2008
- Characteristics of apathy in Parkinson's diseaseMovement Disorders, 2007
- Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Effects of Methylphenidate on Cognitive Function and Gait in Patients With Parkinson's DiseaseClinical Neuropharmacology, 2006
- The dopamine transporter: Importance in Parkinson's diseaseAnnals of Neurology, 2004
- Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse.Journal of Neurology, Neurosurgery & Psychiatry, 1989